Oncology Institute Inc
NASDAQ:TOI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncology Institute Inc
NASDAQ:TOI
|
US |
|
Bank of Nova Scotia
TSX:BNS
|
CA |
|
Holmen AB
OTC:HLMMF
|
SE |
|
P
|
Parkway Life Real Estate Investment Trust
OTC:PRKWF
|
SG |
|
Asetek A/S
F:A31
|
DK |
|
N
|
NSL Foods PCL
SET:NSL
|
TH |
|
Serco Group PLC
LSE:SRP
|
UK |
|
B
|
Borregaard ASA
SWB:BO4
|
NO |
Wall St Price Targets
TOI Price Targets Summary
Oncology Institute Inc
According to Wall Street analysts, the average 1-year price target for TOI is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TOI's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for TOI is 7.14 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.
What is the Revenue forecast for Oncology Institute Inc?
Projected CAGR
28%
Over the last 6 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 2 years is 28%.
What is the Gross Profit forecast for Oncology Institute Inc?
Projected CAGR
36%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 2 years is 36%.
